Creat membership Creat membership
Sign in

Forgot password?

Confirm
  • Forgot password?
    Sign Up
  • Confirm
    Sign In
Creat membership Creat membership
Sign in

Forgot password?

Confirm
  • Forgot password?
    Sign Up
  • Confirm
    Sign In
Collection

toTop

If you have any feedback, Please follow the official account to submit feedback.

Turn on your phone and scan

home > search >

Fibronectin upregulates cGMP-dependent protein kinase type I beta through C/EBP transcription factor activation in contractile cells

Author:
Chamorro-Jorganes, Aranzazu  Calleros, Laura  Griera, Mercedes  Saura, Marta  Luengo, Alicia  Rodriguez-Puyol, D.  Rodriguez-Puyol, M.  


Journal:
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY


Issue Date:
2011


Abstract(summary):

Chamorro-Jorganes A, Calleros L, Griera M, Saura M, Luengo A, Rodriguez-Puyol D, Rodriguez-Puyol M. Fibronectin upregulates cGMP-dependent protein kinase type I beta through C/EBP transcription factor activation in contractile cells. Am J Physiol Cell Physiol 300: C683-C691, 2011. First published December 15, 2010; doi: 10.1152/ajpcell.00251.2010.-The nitric oxide (NO)-soluble guanylate cyclase (sGC) pathway exerts most of its cellular actions through the activation of the cGMP-dependent protein kinase (PKG). Accumulation of extracellular matrix is one of the main structural changes in pathological conditions characterized by a decreased activity of this pathway, such as hypertension, diabetes, or aging, and it is a well-known fact that extracellular matrix proteins modulate cell phenotype through the interaction with membrane receptors such as integrins. The objectives of this study were 1) to evaluate whether extracellular matrix proteins, particularly fibronectin (FN), modulate PKG expression in contractile cells, 2) to analyze the mechanisms involved, and 3) to evaluate the functional consequences. FN increased type I PKG (PKG-I) protein content in human mesangial cells, an effect dependent on the interaction with beta(1)-integrin. The FN upregulation of PKG-I protein content was due to increased mRNA expression, determined by augmented transcriptional activity of the PKG-I promoter region. Akt and the transcription factor CCAAT enhancer-binding protein (C/EBP) mediated the genesis of these changes. FN also increased PKG-I in another type of contractile cell, rat vascular smooth muscle cells (RVSMC). Tirofiban, a pharmacological analog of FN, increased PKG-I protein content in RVSMC and rat aortic walls and magnified the hypotensive effect of dibutyryl cGMP in conscious Wistar rats. The present results provide evidence of a mechanism able to increase PKG-I protein content in contractile cells. Elucidation of this novel mechanism provides a rationale for future pharmacotherapy in certain vascular diseases.


Page:
C683---C691


Similar Literature

Submit Feedback

This function is a member function, members do not limit the number of downloads